Advertisements


We are Sorry, This Page doesn't Exist


U.S. IPO Week Ahead: 2 Growth IPOs Kick Off A More Active March

U.S. IPO Week Ahead: 2 Growth IPOs Kick Off A More Active March.....»»

Category: topSource: seekingalphaMar 2nd, 2019

U.S. IPO Week Ahead: 13 IPOs Close Out 3rd Quarter With Biotechs, China And SurveyMonkey

U.S. IPO Week Ahead: 13 IPOs Close Out 3rd Quarter With Biotechs, China And SurveyMonkey.....»»

Category: topSource: seekingalphaSep 22nd, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs

As we step into the final quarter of 2018, biotech stocks have recorded double-digit gains for the year-to-date period. Will the run up continue? Stay tuned to the following events of the upcoming week. read more.....»»

Category: blogSource: benzingaOct 8th, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs

Biotech stocks are staging a rebound following the losses incurred in the week ended Oct. 12 amid catalysts that include the third-quarter earnings s.....»»

Category: earningsSource: benzingaOct 21st, 2018

Topgolf Recovering Ahead Of Plan, Callaway Capitalizing On Golf Demand

Shares of golf equipment manufacturer and Topgolf owner Callaway Golf Company (NYSE: ELY) hit new 52-week highs Tuesday after reporting first-quarter .....»»

Category: blogSource: benzingaMay 11th, 2021

Topgolf Recovering Ahead Of Plan, Callaway Capitalizing On Golf Demand

Shares of golf equipment manufacturer and Topgolf owner Callaway Golf Company (NYSE: ELY) hit new 52-week highs Tuesday after reporting first-quarter earnings. The company saw revenue at $651 million, up 47% year-over-year and w.....»»

Category: smallbizSource: nytMay 11th, 2021

The Ratings Game: Carvana stock rallies after BofA analyst says buy ahead of earnings

Shares of Carvana Co. surged Monday, after BofA Securities analyst Nat Schindler turned bullish on the online car-buying company less than a week before first-quarter results are due, citing signs of "robust demand" and an inventory rebound......»»

Category: topSource: marketwatchMay 3rd, 2021

The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs

Biotech stocks reversed course in the week ended April 16, with the sector re.....»»

Category: blogSource: benzingaApr 17th, 2021

Stocks trading lower ahead of first quarter bank earnings report release

U.S. equity futures traded lower as first-quarter earnings season kicks off unofficially this week when many of the big banks post their January-through-March results......»»

Category: topSource: foxnewsApr 12th, 2021

IPO Preview: Coursera, Compass And Frontier Airlines Lead Busy Week

The IPO market continues to heat up with several big names going public in the first quarter. This week’s list of potential IPOs includes some well-known names for investors to consider. read more.....»»

Category: blogSource: benzingaMar 28th, 2021

The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»

Category: blogSource: benzingaFeb 6th, 2021

The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»

Category: earningsSource: benzingaFeb 6th, 2021

Market Snapshot: Dow futures rise 200 points as investors prepare for Biden inauguration, earnings roll in

Stock-index futures kick off a holiday-shortened week with gains, a day ahead of the inauguration of President-elect Joe Biden and as fourth-quarter earnings season kicks into higher gear......»»

Category: topSource: marketwatchJan 19th, 2021

The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna"s COVID Vaccine And Drugs From Amgen, MacroGenics

Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock reactions to presentations made at hematology and breast cancer conferences. read more.....»»

Category: blogSource: benzingaDec 13th, 2020

Earnings Watch: Time to take a breath as earnings slow, but you may want to avoid the numbers to stay calm

While the tone of first-quarter earnings isn’t particularly encouraging, the pace of reports will finally relax in the week ahead, which is reason enough to breathe a sigh of relief......»»

Category: topSource: marketwatchMay 10th, 2020

Apple Earnings Ahead: Rough Quarter, iPhone Expectations And Getting Back To Business

Like most companies this earnings season, it will hardly be news if Apple, Inc. (NASDAQ: AAPL) reports earnings this week that its quarter was a rough and tumble one. The likelihood of bad news has been widely reported about the Cupertino gia.....»»

Category: earningsSource: benzingaApr 28th, 2020

Analysts Keep Raising Expectations Ahead of Amazon’s Earnings

Amazon.com, a big beneficiary of the coronavirus outbreak, is set to release its first-quarter financial results later this week. Analysts are offering their two cents before the report comes out......»»

Category: blogSource: 247wallstApr 27th, 2020

Oil slide dents futures ahead of bank earnings

U.S. stock index futures retreated on Wednesday for a second time this week, as a slide in oil prices pressured energy stocks ahead of what is expected to be another dismal round of first-quarter earnings reports......»»

Category: topSource: reutersApr 15th, 2020

Wall Street Week Ahead: Fund rebalancing could help buoy stock rebound

Money managers rebalancing their portfolios to boost equity exposure into the end of the quarter may support the nascent stock rally that has followed the steep coronavirus-fueled market drop......»»

Category: topSource: reutersMar 27th, 2020

Exclusive: Tencent-backed WeDoctor invites banks to lead $1 billion Hong Kong IPO, sources say

WeDoctor will push ahead with a Hong Kong listing and invite pitches from investments banks next week to lead an IPO valuing the Chinese healthcare platform at up to $10 billion, two sources with direct knowledge of the matter said......»»

Category: topSource: reutersMar 6th, 2020